Kestra Advisory Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Sell |
16,286
-335
| -2% | -$54K | 0.01% | 936 |
|
|
2025
Q1 | $2.83M | Sell |
16,621
-2,570
| -13% | -$437K | 0.01% | 827 |
|
|
2024
Q4 | $3.19M | Buy |
19,191
+8,669
| +82% | +$1.44M | 0.02% | 772 |
|
|
2024
Q3 | $1.81M | Sell |
10,522
-547
| -5% | -$94K | 0.01% | 998 |
|
|
2024
Q2 | $1.7M | Sell |
11,069
-8,354
| -43% | -$1.29M | 0.01% | 1042 |
|
|
2024
Q1 | $2.99M | Buy |
19,423
+4,694
| +32% | +$722K | 0.02% | 708 |
|
|
2023
Q4 | $2.33M | Sell |
14,729
-1,818
| -11% | -$287K | 0.02% | 733 |
|
|
2023
Q3 | $2.42M | Buy |
16,547
+680
| +4% | +$99.5K | 0.02% | 624 |
|
|
2023
Q2 | $2.43M | Sell |
15,867
-971
| -6% | -$149K | 0.02% | 606 |
|
|
2023
Q1 | $2.61M | Buy |
16,838
+252
| +2% | +$39.1K | 0.03% | 554 |
|
|
2022
Q4 | $2.56M | Buy |
16,586
+3,369
| +25% | +$519K | 0.02% | 646 |
|
|
2022
Q3 | $1.74M | Sell |
13,217
-28
| -0.2% | -$3.7K | 0.02% | 726 |
|
|
2022
Q2 | $1.8M | Sell |
13,245
-2,394
| -15% | -$324K | 0.02% | 713 |
|
|
2022
Q1 | $2.33M | Sell |
15,639
-5,194
| -25% | -$775K | 0.02% | 620 |
|
|
2021
Q4 | $3.37M | Sell |
20,833
-1,809
| -8% | -$293K | 0.03% | 497 |
|
|
2021
Q3 | $3.76M | Sell |
22,642
-14,232
| -39% | -$2.36M | 0.04% | 482 |
|
|
2021
Q2 | $6.37M | Sell |
36,874
-3,425
| -8% | -$591K | 0.07% | 304 |
|
|
2021
Q1 | $6.47M | Sell |
40,299
-9,755
| -19% | -$1.57M | 0.08% | 276 |
|
|
2020
Q4 | $8.47M | Buy |
50,054
+6,902
| +16% | +$1.17M | 0.1% | 231 |
|
|
2020
Q3 | $6.8M | Buy |
+43,152
| New | +$6.8M | 0.13% | 193 |
|